Developer docs
API playgroundTry for free, no card

Search company profiles

iGEM TU Eindhoven

Full company profile

uuid004mg88

Namestring
iGEM TU Eindhoven
Legal namestring
Stichting iGEM Eindhoven
Company typeenum
Private
Founded yearint
2012
Descriptiontext

iGEM TU Eindhoven is a multidisciplinary student team from Eindhoven University of Technology (TU/e) that designs and builds an annual synthetic biology project for the international iGEM competition. Organized as a Dutch foundation (Stichting iGEM Eindhoven, Chamber of Commerce: 80850154) since 2012, the team draws approximately 50 student members from biology, engineering, computer science, and design disciplines each year, recruited through TU/e channels in January. The organization operates within TU/e's research ecosystem, leveraging facilities and mentorship from the Institute for Complex Molecular Systems (ICMS) and Eindhoven Innovation Space.

The team's annual competition portfolio spans therapeutic, diagnostic, and biomaterial applications of synthetic biology. Notable projects include !MPACT (2022), a CAR-T-style cell therapy for ANCA-associated vasculitis that won the overall iGEM world championship; cELPro (2023), a probiotic E. coli delivering interleukin-10 for inflammatory bowel disease that took first prize in therapeutics; PROMISE (2024), a bacterial membrane vesicle vaccine platform for lung cancer that has been filed as a patent; and BRIGHT (2025), a non-invasive bile-acid biosensor for gastrointestinal diagnostics that placed top-5 in multiple categories. Each project is documented on an open-access iGEM wiki and paired with structured human-practices engagement.

iGEM TU Eindhoven runs a non-commercial model funded by institutional grants and a three-tier corporate sponsorship program (Bronze, Silver, Gold) that provides logo placement, event access, and merchandising rights. Core institutional partners include TU/e, ICMS, Innovation Space, and University Fund Eindhoven; technology sponsors include QIAGEN, Promega, IDT, Demcon, and Cell Signaling Technology / BIOKÉ. The team operates two flagship events — Challenge Day (a free outreach program for regional high school students) and the Mini Jamboree (an annual showcase hosting iGEM teams from the Netherlands, Belgium, Germany, and Luxembourg) — with no pricing model or commercial product sales. The only documented IP asset is the filed PROMISE patent.

Short descriptiontext

iGEM TU Eindhoven is a multidisciplinary student team from Eindhoven University of Technology that designs synthetic biology projects for the international iGEM competition. Founded in 2012 as a Dutch foundation, it runs Challenge Day and Mini Jamboree educational events.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersEindhoven, Netherlands
HQ citystring
Eindhoven
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
synthetic biology research, student competition team, biotechnology education, biomedical research projects, science outreach events
Industry1 code
PRIMARYEDAMAGAB
Model United Nations (MUN)
Education/Supplemental & Enrichment Programs (Arts, STEM, Language)/Academic Clubs & Competitions (Debate, Model UN, Olympiads)
NAICS code2 codes
  • Testing Laboratories and Services54138
  • Technical and Trade Schools6115
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Synthetic Biology Research
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Partnership Sponsorship
TypeProfessional Services
Description

Partnerships with companies and organizations provide financial support, resources, and expertise. Three-tier sponsorship packages (Bronze, Silver, Gold) offering various perks including logo visibility, event access, and networking opportunities.

igemtueindhoven.nl
2Institutional Funding
TypeProfessional Services
Description

Funding from university partners (TU/e, University Fund Eindhoven) and research institutes (ICMS, Innovation Space) for project development and competition participation.

igemtueindhoven.nl
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

iGEM TU Eindhoven is a multidisciplinary student team from Eindhoven University of Technology that designs and builds an annual synthetic biology project for the international iGEM competition, addressing real-world biomedical challenges through cell therapies, vaccine platforms, probiotics, biosensors, and biomaterials. Beyond competition projects, the team organizes two educational events: the Mini Jamboree showcase for regional iGEM teams and Challenge Day for high school students.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • World Champions in 2022 iGEM competition
+3 more records
Product overview1 text field

iGEM TU Eindhoven is a multidisciplinary student team from Eindhoven University of Technology participating in the annual international iGEM synthetic biology competition. The organization operates two main programs: Mini Jamboree (annual showcase event for iGEM teams) and Challenge Day (educational event for high school students). Beyond these programs, the team develops synthetic biology research projects annually, ranging from therapeutic treatments (cell therapies, vaccines, probiotics) to diagnostic tools (biosensors, imaging agents) and novel biomaterials.

Product and service6 records
1Mini Jamboree
CategoryEducational Event
Description

Annual showcase event where international iGEM student teams come together to present their projects, share ideas, and collaborate on synthetic biology solutions. Held at TU Eindhoven Auditorium for iGEM teams from the Netherlands, Belgium, Germany, and Luxembourg. Free admission.

2Challenge Day
CategoryEducational Event
Description

Interactive educational event where high school students learn about synthetic biology and work on a challenge in teams, including hands-on lab experiments and a murder mystery biochemistry case. Free admission.

3!MPACT Cell Therapy
CategoryCell Therapy Research Project
Description

Modular and Personalized Autoimmune Cell Therapy using patient's own immune cells genetically modified to produce an anti-inflammatory response upon targeting pathogenic ANCA disease markers. Developed as the 2022 iGEM competition project.

4PROMISE Vaccine Platform
CategoryVaccine Platform Research Project
Description

Vaccine platform using antigen-functionalized bacterial membrane vesicles (BMVs) that reprograms innate immune cells without replication risks. Modular design allows adaptation for various diseases with potential for personalized treatments. Patented.

5BRIGHT Biosensor
CategoryDiagnostic Biosensor Research Project
Description

Novel biosensor for detecting bile acids in feces using synthetic biology principles for non-invasive diagnostic tool development. Won special prize for best presentation and top 5 in diagnostics at the 2025 iGEM competition.

6cELPro Microbe-Based Therapy
CategoryTherapeutic Research Project
Description

Affordable microbe-based therapy for Inflammatory Bowel Disease using Elastin-Like Polypeptides (ELPs) to modify E. coli to form intracellular hydrogel preventing cell division while producing anti-inflammatory Interleukin 10. Won first prize in therapeutics at the 2023 iGEM competition.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Home base and key partner providing access to state-of-the-art facilities, resources, and expertise in synthetic biology. Critical infrastructure for all project activities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading research institute in synthetic biology providing advanced research facilities, expertise, and mentorship essential for project development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Platform for startups and student teams providing funding, mentorship, and access to network of entrepreneurs and investors to help develop projects.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborative platform of EWUU alliance mobilizing expertise from TU/e, Wageningen, Utrecht, and UMC Utrecht for breakthrough synthetic biology research.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partner testimonial confirms value of annual mini-Jamboree for networking and brand recognition among universities and future professionals.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Global leader in molecular diagnostics and sample-to-insight solutions, already a partner of iGEM TU Eindhoven. Comparable because its nucleic acid purification, PCR, and diagnostic assay technologies intersect with the team's BRIGHT biosensor and IBDETECTION diagnostic projects.

TypeOthers
Description

Manufacturer of recombinant enzymes and reagents for synthetic biology research. Comparable as a reagent and enzyme supplier ecosystem player that the team's molecular biology workflows depend on, similar to partners QIAGEN and Promega.

TypeEmerging player
Description

Provider of synthetic RNA, genome editing tools, and CRISPR reagents used by synthetic biology researchers. Comparable as a tooling partner for the same gene-editing and cell-engineering workflows the team uses for its cell therapy and biosensor projects.

TypeBroad incumbent
Description

Engineered enzyme and synthetic biology company serving therapeutics and industrial biotech. Comparable because it translates engineered biological systems into commercial products — the trajectory iGEM TU Eindhoven's PROMISE and !MPACT platforms could follow.

5Amyris
TypeBroad incumbent
Description

Synthetic biology company that engineers yeast and microbes to produce sustainable ingredients and therapeutics. Comparable as a broad synthetic biology incumbent pursuing the same design-build-test paradigm that iGEM TU Eindhoven applies to its annual projects.

TypeBroad incumbent
Description

Foundry-style synthetic biology company that engineers organisms for industrial and therapeutic applications. Comparable because it operates at the same intersection of genetic engineering, biosensors, and cell therapy platforms that iGEM TU Eindhoven prototypes annually.

TypeEmerging player
Description

Clinical-stage synthetic biology company developing engineered probiotic therapeutics, including for inflammatory bowel disease. Direct comparability to the team's cELPro engineered E. coli probiotic for IBD, which targets the same disease area with a similar microbe-based therapeutic approach.

TypeBroad incumbent
Description

Synthetic biology company manufacturing synthetic DNA and gene fragments at scale. Comparable because the team's projects (e.g., BRIGHT, IBDETECTION) rely on the same DNA synthesis and oligos workflows that Twist commercializes, and IDT (a Twist subsidiary) is already a partner.

TypeOthers
Description

World-leading manufacturer of custom oligonucleotides and CRISPR genome editing tools, already a partner of iGEM TU Eindhoven. Comparable as a supplier of the synthetic DNA and molecular biology tools underpinning the team's projects.

TypeOthers
Description

The international non-profit that organizes the iGEM competition in which iGEM TU Eindhoven participates. Comparable as the parent ecosystem organization that sets competition standards, judges projects, and hosts the Grand Jamboree in Paris.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

iGEM TU Eindhoven

Synthetic Biology Researchigemtueindhoven.nl

iGEM TU Eindhoven is a multidisciplinary student team from Eindhoven University of Technology that designs synthetic biology projects for the international iGEM competition. Founded in 2012 as a Dutch foundation, it runs Challenge Day and Mini Jamboree educational events.

What iGEM TU Eindhoven does

iGEM TU Eindhoven is a multidisciplinary student team from Eindhoven University of Technology (TU/e) that designs and builds an annual synthetic biology project for the international iGEM competition. Organized as a Dutch foundation (Stichting iGEM Eindhoven, Chamber of Commerce: 80850154) since 2012, the team draws approximately 50 student members from biology, engineering, computer science, and design disciplines each year, recruited through TU/e channels in January. The organization operates within TU/e's research ecosystem, leveraging facilities and mentorship from the Institute for Complex Molecular Systems (ICMS) and Eindhoven Innovation Space.

The team's annual competition portfolio spans therapeutic, diagnostic, and biomaterial applications of synthetic biology. Notable projects include !MPACT (2022), a CAR-T-style cell therapy for ANCA-associated vasculitis that won the overall iGEM world championship; cELPro (2023), a probiotic E. coli delivering interleukin-10 for inflammatory bowel disease that took first prize in therapeutics; PROMISE (2024), a bacterial membrane vesicle vaccine platform for lung cancer that has been filed as a patent; and BRIGHT (2025), a non-invasive bile-acid biosensor for gastrointestinal diagnostics that placed top-5 in multiple categories. Each project is documented on an open-access iGEM wiki and paired with structured human-practices engagement.

iGEM TU Eindhoven runs a non-commercial model funded by institutional grants and a three-tier corporate sponsorship program (Bronze, Silver, Gold) that provides logo placement, event access, and merchandising rights. Core institutional partners include TU/e, ICMS, Innovation Space, and University Fund Eindhoven; technology sponsors include QIAGEN, Promega, IDT, Demcon, and Cell Signaling Technology / BIOKÉ. The team operates two flagship events — Challenge Day (a free outreach program for regional high school students) and the Mini Jamboree (an annual showcase hosting iGEM teams from the Netherlands, Belgium, Germany, and Luxembourg) — with no pricing model or commercial product sales. The only documented IP asset is the filed PROMISE patent.

iGEM TU Eindhoven firmographics

Firmographics
Name
iGEM TU Eindhoven
Legal name
Stichting iGEM Eindhoven
Website
https://igemtueindhoven.nl
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1–10 employees
Short description
iGEM TU Eindhoven is a multidisciplinary student team from Eindhoven University of Technology that designs synthetic biology projects for the international iGEM competition. Founded in 2012 as a Dutch foundation, it runs Challenge Day and Mini Jamboree educational events.
Ownership category
akta.pro rank

iGEM TU Eindhoven industry classification

Industry
Product category
Synthetic Biology Research
NAICS
Testing Laboratories and Services (54138), Technical and Trade Schools (6115)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYEDAMAGAB
Model United Nations (MUN)
Education/Supplemental & Enrichment Programs (Arts, STEM, Language)/Academic Clubs & Competitions (Debate, Model UN, Olympiads)

Keywords

  • Synthetic biology research
  • Student competition team
  • Biotechnology education
  • Biomedical research projects
  • Science outreach events

Where iGEM TU Eindhoven is headquartered

Location

Headquarters

HQ city
Eindhoven
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

iGEM TU Eindhoven business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Partnership Sponsorship: Partnerships with companies and organizations provide financial support, resources, and expertise. Three-tier sponsorship packages (Bronze, Silver, Gold) offering various perks including logo visibility, event access, and networking opportunities.
  2. Institutional Funding: Funding from university partners (TU/e, University Fund Eindhoven) and research institutes (ICMS, Innovation Space) for project development and competition participation.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

iGEM TU Eindhoven product offering

Product offering

Core offering

iGEM TU Eindhoven is a multidisciplinary student team from Eindhoven University of Technology that designs and builds an annual synthetic biology project for the international iGEM competition, addressing real-world biomedical challenges through cell therapies, vaccine platforms, probiotics, biosensors, and biomaterials. Beyond competition projects, the team organizes two educational events: the Mini Jamboree showcase for regional iGEM teams and Challenge Day for high school students.

Product overview

iGEM TU Eindhoven is a multidisciplinary student team from Eindhoven University of Technology participating in the annual international iGEM synthetic biology competition. The organization operates two main programs: Mini Jamboree (annual showcase event for iGEM teams) and Challenge Day (educational event for high school students). Beyond these programs, the team develops synthetic biology research projects annually, ranging from therapeutic treatments (cell therapies, vaccines, probiotics) to diagnostic tools (biosensors, imaging agents) and novel biomaterials.

Differentiator

Problem solved

Functional benefit

Products and services

  • Mini Jamboree Annual showcase event where international iGEM student teams come together to present their projects, share ideas, and collaborate on synthetic biology solutions. Held at TU Eindhoven Auditorium for iGEM teams from the Netherlands, Belgium, Germany, and Luxembourg. Free admission.
  • Challenge Day Interactive educational event where high school students learn about synthetic biology and work on a challenge in teams, including hands-on lab experiments and a murder mystery biochemistry case. Free admission.
  • !MPACT Cell Therapy Modular and Personalized Autoimmune Cell Therapy using patient's own immune cells genetically modified to produce an anti-inflammatory response upon targeting pathogenic ANCA disease markers. Developed as the 2022 iGEM competition project.
  • PROMISE Vaccine Platform Vaccine platform using antigen-functionalized bacterial membrane vesicles (BMVs) that reprograms innate immune cells without replication risks. Modular design allows adaptation for various diseases with potential for personalized treatments. Patented.
  • BRIGHT Biosensor Novel biosensor for detecting bile acids in feces using synthetic biology principles for non-invasive diagnostic tool development. Won special prize for best presentation and top 5 in diagnostics at the 2025 iGEM competition.
  • cELPro Microbe-Based Therapy Affordable microbe-based therapy for Inflammatory Bowel Disease using Elastin-Like Polypeptides (ELPs) to modify E. coli to form intracellular hydrogel preventing cell division while producing anti-inflammatory Interleukin 10. Won first prize in therapeutics at the 2023 iGEM competition.

Quantifiable outcome

  • World Champions in 2022 iGEM competition
  • +3 more outcomes

Companies that use iGEM TU Eindhoven

Customer profile

Segments3 records

Ideal customer profiles3 records

iGEM TU Eindhoven technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

iGEM TU Eindhoven partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • TU/e (Eindhoven University of Technology)coreStrategic or Co-development PartnerHome base and key partner providing access to state-of-the-art facilities, resources, and expertise in synthetic biology. Critical infrastructure for all project activities.
  • ICMS (Institute for Complex Molecular Systems)coreStrategic or Co-development PartnerLeading research institute in synthetic biology providing advanced research facilities, expertise, and mentorship essential for project development.
  • Innovation Space (Eindhoven Innovation Space)coreStrategic or Co-development PartnerPlatform for startups and student teams providing funding, mentorship, and access to network of entrepreneurs and investors to help develop projects.
  • CLT (Centre for Living Technologies)minorStrategic or Co-development PartnerCollaborative platform of EWUU alliance mobilizing expertise from TU/e, Wageningen, Utrecht, and UMC Utrecht for breakthrough synthetic biology research.
  • Cell Signaling Technology / BIOKÉminorGTM or Marketing PartnerPartner testimonial confirms value of annual mini-Jamboree for networking and brand recognition among universities and future professionals.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

iGEM TU Eindhoven competitors and assessment

Company assessment

Others

  • QIAGEN: Global leader in molecular diagnostics and sample-to-insight solutions, already a partner of iGEM TU Eindhoven. Comparable because its nucleic acid purification, PCR, and diagnostic assay technologies intersect with the team's BRIGHT biosensor and IBDETECTION diagnostic projects.
  • New England Biolabs: Manufacturer of recombinant enzymes and reagents for synthetic biology research. Comparable as a reagent and enzyme supplier ecosystem player that the team's molecular biology workflows depend on, similar to partners QIAGEN and Promega.
  • Integrated DNA Technologies (IDT): World-leading manufacturer of custom oligonucleotides and CRISPR genome editing tools, already a partner of iGEM TU Eindhoven. Comparable as a supplier of the synthetic DNA and molecular biology tools underpinning the team's projects.
  • iGEM Foundation: The international non-profit that organizes the iGEM competition in which iGEM TU Eindhoven participates. Comparable as the parent ecosystem organization that sets competition standards, judges projects, and hosts the Grand Jamboree in Paris.

Emerging players

  • Synthego: Provider of synthetic RNA, genome editing tools, and CRISPR reagents used by synthetic biology researchers. Comparable as a tooling partner for the same gene-editing and cell-engineering workflows the team uses for its cell therapy and biosensor projects.
  • Synlogic: Clinical-stage synthetic biology company developing engineered probiotic therapeutics, including for inflammatory bowel disease. Direct comparability to the team's cELPro engineered E. coli probiotic for IBD, which targets the same disease area with a similar microbe-based therapeutic approach.

Broad incumbents

  • Codexis: Engineered enzyme and synthetic biology company serving therapeutics and industrial biotech. Comparable because it translates engineered biological systems into commercial products — the trajectory iGEM TU Eindhoven's PROMISE and !MPACT platforms could follow.
  • Amyris: Synthetic biology company that engineers yeast and microbes to produce sustainable ingredients and therapeutics. Comparable as a broad synthetic biology incumbent pursuing the same design-build-test paradigm that iGEM TU Eindhoven applies to its annual projects.
  • Ginkgo Bioworks: Foundry-style synthetic biology company that engineers organisms for industrial and therapeutic applications. Comparable because it operates at the same intersection of genetic engineering, biosensors, and cell therapy platforms that iGEM TU Eindhoven prototypes annually.
  • Twist Bioscience: Synthetic biology company manufacturing synthetic DNA and gene fragments at scale. Comparable because the team's projects (e.g., BRIGHT, IBDETECTION) rely on the same DNA synthesis and oligos workflows that Twist commercializes, and IDT (a Twist subsidiary) is already a partner.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

iGEM TU Eindhoven social profiles

Digital presence

iGEM TU Eindhoven financial estimates

Financial estimate

Revenue estimate

Valuation estimate

iGEM TU Eindhoven leadership team

Management profile

Number of profiles

Profiles9 records

iGEM TU Eindhoven funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

iGEM TU Eindhoven M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iGEM TU Eindhoven

What does iGEM TU Eindhoven do?

iGEM TU Eindhoven is a multidisciplinary student team from Eindhoven University of Technology that designs and builds an annual synthetic biology project for the international iGEM competition, addressing real-world biomedical challenges through cell therapies, vaccine platforms, probiotics, biosensors, and biomaterials. Beyond competition projects, the team organizes two educational events: the Mini Jamboree showcase for regional iGEM teams and Challenge Day for high school students.

Is iGEM TU Eindhoven a public or private company?

iGEM TU Eindhoven is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was iGEM TU Eindhoven founded?

iGEM TU Eindhoven was founded in 2012. It employs 1 to 10 people.

Where is iGEM TU Eindhoven based?

iGEM TU Eindhoven is headquartered in Eindhoven, Netherlands, in the Europe region.

How does iGEM TU Eindhoven make money?

Two revenue lines are on record. Partnership Sponsorship is the primary driver. The others are institutional Funding.

Who are iGEM TU Eindhoven's main competitors?

Others on record are QIAGEN, New England Biolabs, Integrated DNA Technologies (IDT) and iGEM Foundation. Emerging players are Synthego and Synlogic. Broad incumbents are Codexis, Amyris, Ginkgo Bioworks and Twist Bioscience.

Does iGEM TU Eindhoven have an API?

No public API is recorded for iGEM TU Eindhoven.

What industry is iGEM TU Eindhoven in?

iGEM TU Eindhoven's product category is Synthetic Biology Research. Its primary akta.pro industry code is EDAMAGAB, Model United Nations (MUN). Its NAICS code is 54138 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals